Comparing Treatments in Early-Stage Pediatric Hodgkin Lymphoma
Presently, there is no well-defined standard of care for managing pediatric patients with...
chemotherapy
Extending Survival After Inoperable Pancreatic Cancer
Surgical resection of adenocarcinoma can significantly improve survival, but only 20% of patients...
New Guidelines for Head & Neck Cancer Reirradiation
Recurrent and second primary head-and-neck squamous cell carcinomas (HNSCC) arising within or close to previously irradiated areas are a significant clinical challenge. Salvage surgical resection is the standard of care, but...
Agent Approved for Highly Toxic Chemotherapy Levels
The FDA has approved glucarpidase (Voraxaze, BTG International) for treating patients with toxic levels of methotrexate—a type of chemotherapy—in the blood due to kidney failure. The drug breaks down methotrexate to a form that...
A New Guide for Using Antiemetics
A significant proportion of all cancer patients experience nausea or vomiting during the course of their treatment. Nausea and vomiting have long been common adverse effects from certain types of cancer therapy and can lead to...
The Impact of Complications on Colorectal Cancer Care
Colorectal cancer (CRC) is diagnosed in almost 150,000 patients in the United States each year and is the second leading cause of cancer-related death, accounting for more than 50,000 mortalities annually. The use of adjuvant...
The Burden of Pain & Depression in Cancer Patients
The role of somatic symptoms has been investigated in many studies and in various clinical settings because of its impact on patients. Studies have shown that somatic symptoms are frequently persistent, accounting for more than...
Good Nutrition Critical to Chemotherapy
Great strides have been made in treating cancer to achieve a 5-year survival rate of 68%. Targeted therapies and advances in genetics are enabling more personalized patient care for several cancer types. Treating cancer patients...
Updated Practice Guidelines for Ovarian Cancer
A major challenge in treating ovarian cancer is that by the time most patients are diagnosed with the disease, it has already progressed to stage III or IV. The difficult-to-examine location of the ovaries deep in the pelvis...
Rapid Desensitization for Chemotherapy Allergies
Chemotherapy in the 21st century is only now beginning to evolve from its early, traumatic...
Preventing Delayed CINV to Improve Patient Outcomes
Chemotherapy-induced nausea and vomiting (CINV) remains a major adverse effect of cancer chemotherapy, despite the availability of several antiemetic drug classes. Although not life-threatening, CINV has a major impact on a...
American Society of Clinical Oncology 2010
The American Society of Clinical Oncology, or ASCO, held its 2010 annual meeting from June 4 to 8 in Chicago. The features below highlight some of the news emerging from the meeting. » A New Screening Strategy for Ovarian Cancer...
